San Francisco California Metro based Cureline, Inc. has secured $2,000,000.00 in new commercial capital.
Brisbane, CA — Cureline, Inc. has secured $2,000,000.00 in new commercial financing for expansion opportunities in Brisbane. According to the company website, Cureline is a global precision and translational medicine CRO located in California (USA). With more than a hundred validated clinical partners in 20 countries, HBS repository in San Francisco Bay area and excellence in laboratory services, Cureline provides a full spectrum of translational research services: global regulatory affairs, custom protocol HBS biobanking, histopathology & digital pathology, molecular and cellular lab services, small animal studies and cell and gene therapy (ATMP) solutions. Since 2003 Cureline is a global leader in commercial biobanking and biomedical research services with a focus on targeted drug R&D, biomarker research and companion diagnostics development.
To learn more about Cureline, Inc. please visit: http://www.cureline.com/
Company Contact:
Cureline, Inc.
415-468-6400
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.